M
Medivis
A New York City-based medical technology company harnessing augmented reality and artificial intelligence to advance medical imaging and surgical navigation
About Medivis
Medivis is a pioneering company in the healthcare sector, specializing in augmented reality (AR) and artificial intelligence (AI) to revolutionize medical imaging and surgical precision. Founded by a team of surgeons, radiologists, and engineers, Medivis aims to create a holographic future for surgery. The company operates primarily in the medical and healthcare markets, serving hospitals, surgical centers, and educational institutions.
Read full description
Medivis offers two main products: SurgicalAR and AnatomyX. SurgicalAR leverages AR to improve patient outcomes by enhancing surgical visualization and navigation. AnatomyX uses immersive AR technology to engage students in health education, thereby improving learning outcomes. These products are designed to integrate seamlessly with existing medical systems, providing a significant upgrade in terms of precision and efficiency.
The business model of Medivis involves selling its software solutions to healthcare providers and educational institutions. The company generates revenue through software licensing, subscription fees, and partnerships with technology giants like Microsoft and Verizon. Medivis has also secured FDA clearance for its AR surgical system, adding a layer of credibility and trust to its offerings.
Medivis recently closed a $2.3 million funding round to further develop its AR surgical platform, indicating strong investor confidence in its technology and market potential. The company is also collaborating with the Department of Veterans Affairs (VA) to advance healthcare services for veterans, showcasing its commitment to improving healthcare outcomes on a broader scale.
At a glance
- Status
- Operational
- Founded
- 2016
- Headquarters
- New York City, United States
- Employees
- 37
- Open positions
- None listed
- Dealroom signal
- 76.1/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Core AI, Immersive Technologies, Spinout, AI Applications, DT and LS, science-based
- Technology
- Artificial Intelligence, Deep Tech, Augmented Reality, Computer Vision
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Medivis.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jun 2023 | $20M | $110M | Kevin Durant · Hugo Barra · Initialized Capital · Thirty Five Ventures | ↗ |
| EARLY VC✓Equity / VC | Sep 2022 | $22M | $88M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Medivis is 13K monthly website visits, down 23.5% over the last three months. Medivis's team grew 5.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Arkitekt Ventures
Initialized Capital
Series A7 investors entered at this stage
Thrive Capital
Kevin Durant
Hugo Barra
Thirty Five Ventures
Coalition Operators
Mayo Clinic
Robert Spetzler
Other known investors4 additional known investors
New York University
Alumni Ventures
Enke Bashllari
Future Labs
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Medivis on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Medivis’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.